Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sherer

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
ACS Medicinal Chemistry Letters|March 18, 2016
Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDIJoseph E Pero, Michael A Rossi, Michael J Kelly, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
Rapid development of two factor IXa inhibitors from hit to leadDann L Parker, Shawn Walsh, Bing Li, et al.
The Journal of Organic Chemistry|November 27, 2018
Highly Diastereoselective Synthesis of a HCV NS5B Nucleoside Polymerase InhibitorYong-Li Zhong, Ed Cleator, Zhijian Liu, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of AnemiaJohn S Debenham, Christina Madsen-Duggan, Matthew J Clements, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2015
Development of a novel class of potent and selective FIXa inhibitorsTing Zhang, Patrick Andre, Thomas J Bateman, et al.
Journal of Medicinal Chemistry|March 3, 2017
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 InhibitorsTim Cernak, Nathan J Gesmundo, Kevin Dykstra, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2017
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>v</sub>1.7 inhibitors with pain efficacy in miceAnthony J Roecker, Melissa Egbertson, Kristen L G Jones, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2015
Development of a novel tricyclic class of potent and selective FIXa inhibitorsDongfang Meng, Patrick Andre, Thomas J Bateman, et al.
Journal of Medicinal Chemistry|February 28, 2012
1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemiaPetr Vachal, Shouwu Miao, Joan M Pierce, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
ACS Medicinal Chemistry Letters|March 18, 2016
Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDIJoseph E Pero, Michael A Rossi, Michael J Kelly, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
Rapid development of two factor IXa inhibitors from hit to leadDann L Parker, Shawn Walsh, Bing Li, et al.
The Journal of Organic Chemistry|November 27, 2018
Highly Diastereoselective Synthesis of a HCV NS5B Nucleoside Polymerase InhibitorYong-Li Zhong, Ed Cleator, Zhijian Liu, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of AnemiaJohn S Debenham, Christina Madsen-Duggan, Matthew J Clements, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2015
Development of a novel class of potent and selective FIXa inhibitorsTing Zhang, Patrick Andre, Thomas J Bateman, et al.
Journal of Medicinal Chemistry|March 3, 2017
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 InhibitorsTim Cernak, Nathan J Gesmundo, Kevin Dykstra, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2017
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>v</sub>1.7 inhibitors with pain efficacy in miceAnthony J Roecker, Melissa Egbertson, Kristen L G Jones, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2015
Development of a novel tricyclic class of potent and selective FIXa inhibitorsDongfang Meng, Patrick Andre, Thomas J Bateman, et al.
Journal of Medicinal Chemistry|February 28, 2012
1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemiaPetr Vachal, Shouwu Miao, Joan M Pierce, et al.
Pageof 9